Laekna, Inc. (2105) Gets a Buy from DBSLower TP by 9% to reflect share dilution post fundraising; Re-iterate Buy as we see a higher likelihood that Eli Lilly (LLY US) will license in Laekna’s LAE102 for muscle loss prevention
Laekna, Inc. (2105) Gets a Buy from DBSLower TP by 9% to reflect share dilution post fundraising; Re-iterate Buy as we see a higher likelihood that Eli Lilly (LLY US) will license in Laekna’s LAE102 for muscle loss prevention
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
HK$29.19
Buy
97.23%
Upside
Reiterated
08/13/25
Unknown Analyst
KeyBanc
Not Ranked
KeyBanc
HK$31.24
Buy
111.08%
Upside
Reiterated
06/28/25
Unknown Analyst
China Securities International
Not Ranked
China Securities International
HK$41.3
Buy
179.05%
Upside
Reiterated
06/26/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -15.53% per trade.
Copying Mark Kong CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -21.65% per trade.
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -21.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2105 Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
2
3
3
2
1
Buy
0
2
2
4
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
5
5
6
4
In the current month, 2105 has received 4Buy Ratings, 0Hold Ratings, and 0Sell Ratings. 2105 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
2105 Stock Forecast FAQ
What is HK:2105’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:2105’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:2105, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Laekna, Inc. a Buy, Sell or Hold?
Laekna, Inc. has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Laekna, Inc.’s share price target?
Currently, no data Available
What do analysts say about Laekna, Inc.?
Laekna, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Laekna, Inc.?
To buy shares of HK:2105, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.